Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer.
Prostate Cancer (PCa) diagnosis is currently hampered by the high false-positive rate of PSA evaluations, which consequently may lead to overtreatment. Non-invasive methods with increased specificity and sensitivity are needed to improve diagnosis of significant PCa. We developed and technically val...
Main Authors: | Kathrin Endt, Jens Goepfert, Aurelius Omlin, Alcibiade Athanasiou, Pierre Tennstedt, Anna Guenther, Maurizio Rainisio, Daniel S Engeler, Thomas Steuber, Silke Gillessen, Thomas Joos, Ralph Schiess |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5540289?pdf=render |
Similar Items
-
Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy
by: Aurelius Omlin, et al.
Published: (2014-02-01) -
Analytical performance of thrombospondin-1 and cathepsin D immunoassays part of a novel CE-IVD marked test as an aid in the diagnosis of prostate cancer.
by: Annalisa Macagno, et al.
Published: (2020-01-01) -
In-depth Analysis of the 2019 Advanced Prostate Cancer Consensus Conference: The Importance of Representation of Medical Specialty and Geographic Regions
by: Manolis Pratsinis, et al.
Published: (2021-04-01) -
Similarities and Differences of Blood N-Glycoproteins in Five Solid Carcinomas at Localized Clinical Stage Analyzed by SWATH-MS
by: Tatjana Sajic, et al.
Published: (2018-05-01) -
Development of an immunoassay for the quantification of capsaicinoids in different matrices.
by: Wang, Yong
Published: (1997)